Site Members can sign up for company wide alerts
Investigation Overview
Dec. 26, 2012 (Shareholders Foundation) -- An investigation on behalf of certain investors in shares of Pluristem Therapeutics Inc. (NASDAQ:PSTI) was announced over potential violations of Federal Securities Laws by Pluristem Therapeutics Inc. in connection with certain financial statements. The investigation by a law firm focuses on possible claims on behalf of purchasers of the secu...
You must register (for free) or login to view the entire investigation.